Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionIfrah Financial Services, Inc.
Latest Disclosed Ownership1,301 shares
Latest Disclosed Value $ 457,638
Ifrah Financial Services, Inc. reports 2.33% decrease in ownership of AMGN / Amgen Inc.

On April 22, 2026 - Ifrah Financial Services, Inc. filed a 13F-HR form disclosing ownership of 1,301 shares of Amgen Inc. (MX:AMGN) valued at $457,638 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 1,332 shares of Amgen Inc.. This represents a change in shares of -2.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F AMGEN COM 031162100 1,301 -31 -2.33 458 5.06 0.1210
2026-01-22 2025-12-31 13F AMGEN COM 031162100 1,332 -30 -2.20 436 13.28 0.1120
2025-10-22 2025-09-30 13F AMGEN COM 031162100 1,362 -7 -0.51 384 0.52 0.0997
2025-07-29 2025-06-30 13F AMGEN COM 031162100 1,369 -9 -0.65 382 -10.96 0.1043
2025-04-29 2025-03-31 13F AMGEN COM 031162100 1,378 -64 -4.44 429 14.40 0.1233
2025-01-31 2024-12-31 13F AMGEN COM 031162100 1,442 -19 -1.30 376 -20.21 0.1039
2024-10-31 2024-09-30 13F AMGEN COM 031162100 1,461 -7 -0.48 471 2.62 0.1270
2024-08-05 2024-06-30 13F AMGEN COM 031162100 1,468 -111 -7.03 459 2.00 0.1300
2024-05-06 2024-03-31 13F AMGEN COM 031162100 1,579 -25 -1.56 449 -2.60 0.1259
2024-02-06 2023-12-31 13F AMGEN COM 031162100 1,604 -110 -6.42 462 0.22 0.1355
2023-11-06 2023-09-30 13F AMGEN COM 031162100 1,714 -13 -0.75 461 20.10 0.1434
2023-08-01 2023-06-30 13F AMGEN COM 031162100 1,727 -23 -1.31 383 -9.24 0.1163
2023-05-05 2023-03-31 13F AMGEN COM 031162100 1,750 -248 -12.41 423 -19.47 0.1342
2023-02-06 2022-12-31 13F AMGEN COM 031162100 1,998 -60 -2.92 525 12.93 0.1723
2022-11-07 2022-09-30 13F AMGEN COM 031162100 2,058 -3 -0.15 464 -7.39 0.1594
2022-08-05 2022-06-30 13F AMGEN COM 031162100 2,061 -21 -1.01 501 -0.60 0.1628
2022-05-03 2022-03-31 13F AMGEN COM 031162100 2,082 290 16.18 504 25.06 0.1416
2022-02-01 2021-12-31 13F/A-1 AMGEN COM 031162100 1,792 2 0.11 403 5.77 0.1081
2022-02-01 2021-12-31 13F AMGEN COM 031162100 1,790 0 381 0.1095
2021-11-01 2021-09-30 13F AMGEN COM 031162100 1,790 -3 -0.17 381 -12.81 0.1095
2021-08-05 2021-06-30 13F AMGEN COM 031162100 1,793 -65 -3.50 437 -5.41 0.1251
2021-04-30 2021-03-31 13F AMGEN COM 031162100 1,858 -83 -4.28 462 3.59 0.1389
2021-02-05 2020-12-31 13F AMGEN COM 031162100 1,941 -36 -1.82 446 -11.16 0.1436
2020-11-12 2020-09-30 13F AMGEN COM 031162100 1,977 -31 -1.54 502 5.91 0.1802
2020-08-11 2020-06-30 13F AMGEN COM 031162100 2,008 -83 -3.97 474 11.79 0.1727
2020-05-07 2020-03-31 13F AMGEN COM 031162100 2,091 2 0.10 424 -15.87 0.1777
2020-02-06 2019-12-31 13F AMGEN COM 031162100 2,089 -31 -1.46 504 22.93 0.1776
2019-11-04 2019-09-30 13F AMGEN COM 031162100 2,120 -51 -2.35 410 2.50 0.1502
2019-08-06 2019-06-30 13F AMGEN COM 031162100 2,171 -46 -2.07 400 -4.99 0.1481
2019-05-13 2019-03-31 13F AMGEN COM 031162100 2,217 -31 -1.38 421 -3.88 0.1600
2019-05-13 2018-12-31 13F AMGEN COM 031162100 2,248 -79 -3.39 438 -9.13 0.1847
2018-11-05 2018-09-30 13F AMGEN COM 031162100 2,327 -96 -3.96 482 7.83 0.1704
2018-08-01 2018-06-30 13F AMGEN COM 031162100 2,423 -9 -0.37 447 7.71 0.1618
2018-05-02 2018-03-31 13F AMGEN COM 031162100 2,432 -16 -0.65 415 -2.58 0.1512
2018-02-01 2017-12-31 13F AMGEN COM 031162100 2,448 -1,788 -42.21 426 -46.08 0.1543
2017-11-06 2017-09-30 13F AMGEN COM 031162100 4,236 -7 -0.16 790 8.07 0.2995
2017-08-07 2017-06-30 13F AMGEN COM 031162100 4,243 -153 -3.48 731 1.39 0.2885
2017-05-09 2017-03-31 13F AMGEN COM 031162100 4,396 -85 -1.90 721 10.08 0.2893
2017-02-08 2016-12-31 13F AMGEN COM 031162100 4,481 -360 -7.44 655 -18.94 0.2668
2016-11-07 2016-09-30 13F AMGEN COM 031162100 4,841 4,841 808 0.3217
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.